Enoch Cobbina
Title
Cited by
Cited by
Year
Non-alcoholic fatty liver disease (NAFLD)–pathogenesis, classification, and effect on drug metabolizing enzymes and transporters
E Cobbina, F Akhlaghi
Drug metabolism reviews 49 (2), 197-211, 2017
1582017
Evaluation of the binding of oxovanadium(IV) to human serum albumin
I Correia, T Jakusch, E Cobbinna, S Mehtab, I Tomaz, NV Nagy, ...
Dalton Transactions 41 (21), 6477-6487, 2012
612012
The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study
L Mary R, T Jenica D, G Mwlod, S Melanie L, D Alexandra A, L April N, ...
Molecular Psychiatry, 2018
50*2018
Binding of oxovanadium (IV) complexes to blood serum albumins
E Cobbina, S Mehtab, I Correia, G Gonçalves, I Tomaz, I Cavaco, ...
Journal of the Mexican Chemical Society 57 (3), 180-191, 2013
172013
Endocrine effects of the novel ghrelin receptor inverse agonist PF-5190457: Results from a placebo-controlled human laboratory alcohol co-administration study in heavy drinkers
MR Lee, M Farokhnia, E Cobbina, A Saravanakumar, X Li, JT Battista, ...
Neuropharmacology 170, 107788, 2020
62020
The current status and future of medical laboratory quality regulation and accreditation in Ghana
E Cobbina, JY Agbezudor, PS Amuzu, TK Gyampomah
Accreditation and Quality Assurance 17 (6), 613-619, 2012
52012
Neuroendocrine response to exogenous ghrelin administration, combined with alcohol, in heavy-drinking individuals: Findings from a randomized, double-blind, placebo-controlled …
M Farokhnia, KM Abshire, A Hammer, SL Deschaine, A Saravanakumar, ...
International Journal of Neuropsychopharmacology, 2021
2021
A Population Pharmacokinetic Analysis of PF-5190457, a Novel Ghrelin Receptor Inverse Agonist in Healthy Volunteers and in Heavy Alcohol Drinkers
E Cobbina, MR Lee, L Leggio, F Akhlaghi
Clinical Pharmacokinetics, 1-14, 2020
2020
Development of Bayesian and Non-Bayesian Melphalan Pharmacokinetic Model from Literature-Generated Data
E Cobbina
2019
Quantitative association analyses of CNS safety pharmacology parameters to clinical observations in toxicology studies.
JK DaSilva, E Cobbina, C Tyszkiewicz, D Li, S Goody
Journal of pharmacological and toxicological methods 99, 106595, 2019
2019
In Vitro Drug Metabolism and Population Pharmacokinetics as Tools for Elucidating Pharmacokinetic Variability
E Cobbina
2018
Hepatic lipid accumulation in experimental heparg model for steatosis influences bupropion biotransformation
A Saravanakumar, E Cobbina, X Bush, F Akhlaghi
Drug Metabolism and Pharmacokinetics 33 (1), S30-S31, 2018
2018
Alteration in the intrinsic clearance of CYP2B6 by NAFLD: Evidence of the involvement of the metabolic syndrome in variable drug response
E Cobbina, A Saravanakumar, F Akhlaghi
Drug Metabolism and Pharmacokinetics 33 (1), S81, 2018
2018
National Rates Of 30-Day Hospital Readmissions For Adults With Asthma Exacerbation
A Goizueta, E Cobbina, R Cholankeril, L Gonzalez, R El-Bizri
B25. ASTHMA EPIDEMIOLOGY: EXACERBATIONS, ADMISSIONS, READMISSIONS, AND ED …, 2017
2017
Enlace de Complejos de Oxovanadio (IV) con Albúminas Séricas de Sangre
E Cobbina, S Mehtab, I Correia, G Gonçalves, I Tomaz, I Cavaco, ...
2013
Electronic Supplemental Information
I Correia, T Jakusch, E Cobbinna, S Mehtab, I Tomaz, N Nagy, ...
The system can't perform the operation now. Try again later.
Articles 1–16